Iovance Biotherapeutics Inc.
IOVA | NASDAQ
$10.19
-$0.06 (-0.59%)
At close: Sep 21, 2026, 4:00 PM ET
$10.22
+$0.03 (+0.29%)
Pre-market:
Sep 22, 2026, 8:32 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 99.31M | 71.43M | 86.77M | 67.46M | 59.95M | 49.32M | 73.69M | 58.55M | 31.11M | 715K | 482K | 469K | 238K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 45.13M | 1.02M | -100.53M | 1.41M | 56.66M | 49.74M | 45.54M | 39.82M | 31.37M | 7.26M | 4.37M | 4.34M | 2.05M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 54.18M | 70.41M | 187.3M | 66.05M | 3.29M | -417K | 28.15M | 18.73M | -262K | -6.55M | -3.88M | -3.87M | -1.81M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -51.91M | -81.04M | -73.46M | -94.9M | -113.77M | -121.22M | -86.58M | -89.07M | -101.91M | -117.72M | -121.26M | -118.36M | -110.09M | -110.86M | -107.04M | -100.4M | -99.73M | -91.71M | -99.47M | -86.24M | -81.43M | -75.57M |
Interest Income | n/a | 1.33M | 7.32M | n/a | 4.1M | 3.22M | 9.58M | 4.01M | 3.36M | 3.34M | 3.12M | 3.36M | 3.08M | 3.49M | 1.72M | 777K | 385K | 106K | 135K | 120K | 75K | 121K |
Pretax Income | -48.69M | -79.71M | -71.72M | -93.66M | -109.67M | -118M | -77M | -85.06M | -98.56M | -114.38M | -118.14M | -115M | -107.01M | -107.37M | -105.32M | -99.62M | -99.35M | -91.61M | -99.33M | -86.12M | -81.35M | -75.45M |
Net Income | -47.32M | -79.05M | -71.9M | -91.25M | -111.66M | -116.16M | -78.56M | -83.54M | -97.1M | -112.98M | -116.38M | -113.76M | -106.53M | -107.37M | -105.32M | -99.62M | -99.35M | -91.61M | -99.33M | -86.12M | -81.35M | -75.45M |
Selling & General & Admin | n/a | 38.95M | 36.14M | 34.56M | 37.7M | 43.93M | 42.5M | 39.55M | 34.19M | 26.12M | 29.9M | 26.96M | 21.93M | 28.12M | 26.46M | 27.89M | 26.33M | 23.41M | 23.85M | 20.89M | 19.31M | 19.62M |
Research & Development | 63.93M | 62.49M | 68.85M | 75.17M | 79.36M | 76.88M | 72.22M | 68.25M | 62.08M | 79.78M | 87.47M | 87.53M | 86.35M | 82.73M | 80.57M | 72.5M | 73.41M | 68.3M | 75.62M | 65.36M | 62.12M | 55.95M |
Other Expenses | 42.16M | 50.02M | 155.76M | 51.22M | n/a | n/a | n/a | -1K | 5.38M | 5.27M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 106.09M | 151.45M | 260.76M | 160.95M | 117.06M | 120.8M | 114.73M | 107.8M | 101.65M | 111.18M | 117.37M | 114.49M | 108.27M | 110.86M | 107.04M | 100.4M | 99.73M | 91.71M | 99.47M | 86.24M | 81.43M | 75.57M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | 33.35M | n/a | n/a | n/a | 17.86M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 151.22M | 152.47M | 160.23M | 162.36M | 173.73M | 170.55M | 160.27M | 147.62M | 133.02M | 118.44M | 121.74M | 118.83M | 110.32M | 110.86M | 107.04M | 100.4M | 99.73M | 91.71M | 99.47M | 86.24M | 81.43M | 75.57M |
Income Tax Expense | -1.37M | -665K | 184K | -2.41M | 1.99M | -1.84M | 1.56M | -1.52M | -1.46M | -1.41M | -1.76M | -1.24M | -477K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 450.19M | 418.51M | 406.97M | 364.04M | 334.51M | 322.87M | 304.89M | 303.27M | 284.82M | 266.22M | 255.95M | 245.82M | 224.48M | 213.69M | 164.77M | 157.82M | 157.27M | 157.11M | 156.92M | 155.51M | 153.75M | 147.37M |
Shares Outstanding (Diluted) | 450.19M | 418.51M | 406.97M | 364.04M | 334.51M | 322.87M | 304.89M | 303.27M | 284.82M | 266.22M | 255.95M | 245.82M | 224.48M | 213.69M | 164.77M | 157.82M | 157.27M | 157.11M | 156.92M | 155.51M | 153.75M | 147.37M |
EPS (Basic) | -0.11 | -0.19 | -0.15 | -0.25 | -0.33 | -0.36 | -0.26 | -0.28 | -0.34 | -0.42 | -0.45 | -0.46 | -0.47 | -0.50 | -0.62 | -0.63 | -0.63 | -0.58 | -0.63 | -0.55 | -0.53 | -0.51 |
EPS (Diluted) | -0.11 | -0.19 | -0.15 | -0.25 | -0.33 | -0.36 | -0.26 | -0.28 | -0.34 | -0.42 | -0.45 | -0.46 | -0.47 | -0.50 | -0.62 | -0.63 | -0.63 | -0.58 | -0.63 | -0.55 | -0.53 | -0.51 |
EBITDA | -39.19M | -71.17M | -67.79M | -84.65M | -97.73M | -106.94M | -65.31M | -77.92M | -87.7M | -104.48M | -108.42M | -105.13M | -99.16M | -101.67M | -99.61M | -94.42M | -94.1M | -86.63M | -87.12M | -82.16M | -78.57M | -72.8M |
EBIT | -48.69M | -79.71M | -71.72M | -93.66M | -109.67M | -118M | -77M | -89.07M | -98.56M | -114.38M | -118.14M | -115M | -107.01M | -107.37M | -105.32M | -99.62M | -99.35M | -91.61M | -99.33M | -86.12M | -81.35M | -75.57M |
Depreciation & Amortization | 9.5M | 8.54M | 3.93M | 9.01M | 11.94M | 11.07M | 11.69M | 11.15M | 10.86M | 9.91M | 9.71M | 9.88M | 7.84M | 5.7M | 5.71M | 5.2M | 5.25M | 4.98M | 12.21M | 3.97M | 2.78M | 2.77M |
Add to Watchlist
Select watchlists to add or remove IOVA